Search

XL281

Mutational activation of RAS occurs in about 30 percent of all human tumors, including non-small cell lung, pancreatic, and colon cancer. … XL281 is a specific inhibitor of RAF kinases, including the mutant form of B-RAF, which is activated in 60 percent of melanomas, 24-44 percent of thyroid cancers, and 9 percent of colon cancers.

Indigo

N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate

Cyromazine

Cyromazine is a small molecule drug. Cyromazine has a monoisotopic molecular weight of 166.1 Da.

MIP-1095 I-131

MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

Morrhuic acid

Morrhuic acid is a mixture of unsaturated fatty acids obtained from cod liver oil.

Epicriptine

Epicriptine differs from the alpha form on the position of one methyl group.[T195] To know more about the mixture please visit [DB01049]

Sphingosine

An amino alcohol with a long unsaturated hydrocarbon chain. Sphingosine and its derivative sphinganine are the major bases of the sphingolipids in mammals. (Dorland, 28th ed)

Dehydrocholic acid

The use of dehydrocholic acid in over-the-counter products has been discontinued by Health Canada.

Rabeximod

Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.